Case report: Methotrexate's role as a potential inducer of macrophage activation syndrome in Still's disease

Int J Rheum Dis. 2024 May;27(5):e15183. doi: 10.1111/1756-185X.15183.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Antirheumatic Agents* / adverse effects
  • Antirheumatic Agents* / therapeutic use
  • Female
  • Humans
  • Macrophage Activation Syndrome* / diagnosis
  • Macrophage Activation Syndrome* / drug therapy
  • Macrophage Activation Syndrome* / etiology
  • Male
  • Methotrexate* / therapeutic use
  • Still's Disease, Adult-Onset / diagnosis
  • Still's Disease, Adult-Onset / drug therapy
  • Still's Disease, Adult-Onset / immunology
  • Treatment Outcome

Substances

  • Methotrexate
  • Antirheumatic Agents